The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

Cancer Policy

Trump claims that autism is caused by Tylenol use during pregnancy, advises to “fight like hell not to take it”

Bhattacharya: New grant review criterion is “not political”

Ousted CDC director testifies before Senate HELP Committee

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

AACR survey finds overwhelming public support for federal funding for medical and cancer research

FDA cracks down on direct-to-consumer ads, including the Hims & Hers Superbowl blitz

Clinical Roundup

Study assesses cancers in children exposed to medical imaging

Tecvayli + Darzalex Faspro achieves 100% MRD negativity in newly diagnosed MM, phase II study shows

Mammograms may benefit women well into their 80s, UCLA study finds

Korean researchers find CRC patients over 70 years don’t stand to benefit from chemo

Wistar scientists identify novel therapeutic target for ovarian cancer

ALOX15 loss, common in CRC, impairs the cancer-preventative effects of fish oil, mouse study shows

In The Clinic
Conversation with The Cancer Letter

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account